Opportunities for using in silico-based extended dosing regimens for monoclonal antibody immune checkpoint inhibitors - Peer, C J; Goldstein, D A; Goodell, J C; Nguyen, R; Figg, W D; Ratain, M J (Br J Clin Pharmacol, 2020)